Beximco Sees Turbulence From COVID-19
Remdesivir Success Is Accompanied By Supply Chain Disruption
A mixed picture has emerged for Beximco in its financial third quarter as a result of the coronavirus pandemic, with its success launching the first generic of remdesivir balanced by disruption to the supply chain.
You may also be interested in...
Pakistan’s Searle says it has struck a licensing and marketing deal with Bangladesh’s Beximco to market its generic remdesivir in Pakistan as the country grapples with the coronavirus pandemic.
Bangladesh's Beximco has claimed a world first with the launch of a generic version of remdesivir in its domestic market. Local authorities have granted an emergency use authorization for the COVID-19 treatment amid the coronavirus pandemic.
Gilead has announced a raft of licensing agreements with five generics firms to manufacture potential COVID-19 treatment remdesivir for distribution in 127 countries.